Viral vectors for in vivo gene transfer in Parkinson's disease: Properties and clinical grade production
- 31 January 2008
- journal article
- review article
- Published by Elsevier in Experimental Neurology
- Vol. 209 (1) , 58-71
- https://doi.org/10.1016/j.expneurol.2007.08.008
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Effective High-Capacity Gutless Adenoviral Vectors Mediate Transgene Expression in Human Glioma CellsMolecular Therapy, 2006
- A novel human artificial chromosome gene expression system using herpes simplex virus type 1 vectorsEMBO Reports, 2006
- Quantification of High-Capacity Helper-Dependent Adenoviral Vector Genomes In Vitro and In Vivo, Using Quantitative TaqMan Real-Time Polymerase Chain ReactionHuman Gene Therapy, 2006
- Development and characterization of a cell line for large‐scale, serum‐free production of recombinant adeno‐associated viral vectorsThe Journal of Gene Medicine, 2004
- Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site PreferencesPLoS Biology, 2004
- Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybridsGene Therapy, 2004
- Preexisting Antiadenoviral Immunity Is Not a Barrier to Efficient and Stable Transduction of the Brain, Mediated by Novel High-Capacity Adenovirus VectorsHuman Gene Therapy, 2001
- Neuron-Specific Transduction in the Rat Septohippocampal or Nigrostriatal Pathway by Recombinant Adeno-associated Virus VectorsExperimental Neurology, 1998
- Immune responses to adenovirus vectors in the nervous systemTrends in Neurosciences, 1996
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970